Vaccines Market is Expected to Reach 94.9 billion MarketsandMarkets
Slightly above 67% of VBI Vaccines' investor base is looking to short. The analysis of current outlook of investing in VBI Vaccines suggests that many traders are alarmed regarding VBI Vaccines' prospects. VBI Vaccines' investing sentiment can be driven by a variety of factors including economic data, VBI Vaccines' earnings reports, geopolitical events, and overall market trends.
VBI |
Chicago, May 10, 2024 -- Vaccines market in terms of revenue was estimated to be worth 78.0 billion in 2024 and is poised to reach 94.9 billion by 2029, growing at a CAGR of 4.0 percent from 2024 to 2029 according to a latest report published by MarketsandMarkets. Similarly, the vaccines market is projected to reach USD 80.3 Billion by 2029 from USD 53.0 Billion in 2024, at a CAGR of 8.7 percent during the forecast period. The market growth is fueled by rising
Read at finance.yahoo.com
VBI Vaccines Fundamental Analysis
We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
VBI Vaccines is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
VBI Vaccines Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.
Peers
VBI Vaccines Related Equities
VXRT | Vaxart | 19.67 | ||||
OCGN | Ocugen | 4.94 | ||||
GOVX | GeoVax Labs | 4.68 | ||||
ARDX | Ardelyx | 3.66 | ||||
JAGX | Jaguar Animal | 2.91 | ||||
ANVS | Annovis Bio | 2.13 | ||||
IBIO | Ibio | 1.66 | ||||
AKRO | Akero Therapeutics | 1.16 | ||||
ALLO | Allogene Therapeutics | 0.92 | ||||
ANIX | Anixa Biosciences | 0.39 | ||||
AUPH | Aurinia Pharmaceuticals | 0.54 | ||||
BBIO | BridgeBio Pharma | 1.41 | ||||
TNXP | Tonix Pharmaceuticals | 8.11 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |